Department of Dermatology, New York University School of Medicine, New York, New York 10016, USA.
J Am Acad Dermatol. 2012 May;66(5):699.e1-18; quiz 717-8. doi: 10.1016/j.jaad.2011.11.965.
Sarcoidosis is a common systemic, noncaseating granulomatous disease of unknown etiology. The development of sarcoidosis has been associated with a number of environmental factors and genes. Cutaneous sarcoidosis, the "great imitator," can baffle clinicians because of its diverse manifestations and its ability to resemble both common and rare cutaneous diseases. Depending on the type, location, and distribution of the lesions, treatment can prevent functional impairment, symptomatic distress, scarring, and disfigurement. Numerous therapeutic options are available for the treatment of cutaneous sarcoidosis, but there are few well designed trials to guide practitioners on evidence-based, best practice management. In part I, we review the current knowledge and advances in the epidemiology, etiology, pathogenesis, and genetics of sarcoidosis, discuss the heterogeneous manifestations of cutaneous sarcoidosis, and provide a guide for treatment of cutaneous sarcoidosis.
结节病是一种常见的、病因不明的系统性、非干酪样肉芽肿性疾病。结节病的发生与许多环境因素和基因有关。皮肤结节病,即“伟大的模仿者”,因其多样的表现形式及其既能类似常见皮肤病又能类似罕见皮肤病的能力,使临床医生感到困惑。根据病变的类型、位置和分布,治疗可以预防功能障碍、症状困扰、瘢痕和畸形。有许多治疗选择可用于治疗皮肤结节病,但很少有精心设计的试验来指导从业者进行基于证据的最佳实践管理。在第一部分中,我们回顾了结节病的流行病学、病因、发病机制和遗传学的最新知识和进展,讨论了皮肤结节病的异质性表现,并为皮肤结节病的治疗提供了指导。